• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Envelope-deforming antiviral peptide derived from influenza virus M2 protein

tetano

Editor, Senior Moderator
Biochem Biophys Res Commun. 2019 Jul 30. pii: S0006-291X(19)31442-1. doi: 10.1016/j.bbrc.2019.07.088. [Epub ahead of print]
[h=1]Envelope-deforming antiviral peptide derived from influenza virus M2 protein.[/h] Jung Y[SUP]1[/SUP], Kong B[SUP]1[/SUP], Moon S[SUP]1[/SUP], Yu SH[SUP]1[/SUP], Chung J[SUP]1[/SUP], Ban C[SUP]2[/SUP], Chung WJ[SUP]3[/SUP], Kim SG[SUP]4[/SUP], Kweon DH[SUP]5[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Molecules interfering with lipid bilayer function exhibit strong antiviral activity against a broad range of enveloped viruses, with a lower risk of resistance development than that for viral protein-targeting drugs. Amphipathic peptides are rich sources of such membrane-interacting antivirals. Here, we report that influenza viruses were effectively inactivated by M2 AH, an amphipathic peptide derived from the M2 protein of the influenza virus. Although overall hydrophobicity (<H>) of M2 AH was not related to antiviral activity, modification of the hydrophobic moment (<μH>) of M2 AH dramatically altered the antiviral activity of this peptide. M2 MH, a derivative of M2 AH with a <μH> of 0.874, showed a half maximal inhibitory concentration (IC[SUB]50[/SUB]) of 53.3 nM against the A/PR/8/34 strain (H1N1), which is 16-times lower than that of M2 AH. The selectivity index (IC[SUB]50[/SUB]/CC[SUB]50[/SUB]), where CC[SUB]50[/SUB] is the half maximal cytotoxic concentration, was 360 for M2 MH and 81 for M2 AH. Dynamic light scattering spectroscopy and electron microscopy revealed that M2 AH-derived peptides did not disrupt liposomes but altered the shape of viruses. This result suggests that the shape of virus envelope was closely related to its activity. Thus, we propose that deforming without rupturing the membranes may achieve a high selectivity index for peptide antivirals.
Copyright ? 2019 Elsevier Inc. All rights reserved.


[h=4]KEYWORDS:[/h] Amphipathic peptide; Antiviral peptide; Hydrophobic moment; Influenza virus; M2 protein; Membrane deformation

PMID: 31375212 DOI: 10.1016/j.bbrc.2019.07.088
 
Back
Top Bottom